abstract |
(57) [Summary]nThe present invention relates to 2-arylimino-1,3-thiazolidines, 2-arylimino-2,3,4,5-tetrahydro-1,3-thiazines, 2-arylimino-1,3-thiazolidine-4. 2-arylimino heterocycles, including -ones, 2-arylimino-1,3-thiazolidine-5-ones and 2-arylimino-1,3-oxazolidines, and their regulation of progesterone receptor-mediated processes And pharmaceutical compositions suitable for use in such treatments. |